SAD and MAD Study With IV and SC Doses of ARGX-117
NCT04532125
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
110
Enrollment
INDUSTRY
Sponsor class
Conditions
Healthy Volunteers
Interventions
BIOLOGICAL:
ARGX-117
OTHER:
Placebo
BIOLOGICAL:
ARGX-117 + rHuPH20
OTHER:
placebo + rHuPH20
BIOLOGICAL:
ARGX-117 PH20 SC
OTHER:
Placebo PH20 SC
Sponsor
argenx